Shared on 17 Jul 25
Fair value Decreased 5.41%Despite an improved revenue growth outlook for Kanadevia, a higher discount rate has outweighed these gains, resulting in a lowered consensus analyst price target from ¥1110 to ¥1050. What's in the News Board approved proposal to amend Articles of Incorporation, specifically abolishing the position of Counselors to enhance governance and transparency.
Shared on 01 May 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 2.27%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 3.37%AnalystConsensusTarget has decreased revenue growth from 3.7% to 2.1% and increased discount rate from 6.3% to 7.5%.

